{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T08:13:19Z","timestamp":1648541599887},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1684\/bdc.2011.1305","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T20:01:59Z","timestamp":1565726519000},"page":"146-153","source":"Crossref","is-referenced-by-count":0,"title":["Cancer du canal anal : \u00e9tat des lieux, enjeux en oncog\u00e9riatrie et th\u00e9rapies mol\u00e9culaires cibl\u00e9es"],"prefix":"10.1016","volume":"98","author":[{"given":"Ngoc-Hanh","family":"Hau Desbat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Auberdiac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrus","family":"Chargari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yacine","family":"Merrouche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9ric","family":"Deutsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"de Laroche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Magn\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1684\/bdc.2011.1305_bib0005","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1470-2045(04)01410-X","article-title":"Cancer of the anal canal","volume":"5","author":"Clark","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1684\/bdc.2011.1305_bib0010","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1200\/JCO.2006.07.2587","article-title":"Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas","volume":"24","author":"Chung","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2011.1305_bib0015","first-page":"37","article-title":"Non-AIDS-defining malignancies in HIV patients: clinical features and perspectives","volume":"93","author":"Spano","year":"2006","journal-title":"Bull Cancer"},{"key":"10.1684\/bdc.2011.1305_bib0020","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM200003163421107","article-title":"Carcinoma of the anal canal","volume":"342","author":"Ryan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2011.1305_bib0025","unstructured":"F\u00e9d\u00e9ration francophone de canc\u00e9rologie digestive. http:\/\/www.ffcd.fr"},{"key":"10.1684\/bdc.2011.1305_bib0030","first-page":"212","article-title":"Recommendations for clinical practice: use of TEP-FDG in cancer of the esophagus, stomach, colon and rectum, anal canal, large intestine, pancreas and bile ducts, liver and endocrine tumors (digestive system)","volume":"94","author":"Bourguet","year":"2007","journal-title":"Bull Cancer"},{"key":"10.1684\/bdc.2011.1305_bib0035","series-title":"M\u00e9mento de pathologie","first-page":"105","author":"Adam","year":"2006"},{"key":"10.1684\/bdc.2011.1305_bib0040","series-title":"AJCC Cancer Staging Manual","first-page":"125","year":"2002"},{"key":"10.1684\/bdc.2011.1305_bib0045","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/BF02555448","article-title":"Epidermoid carcinoma of the anal canal. A series of 276 cases","volume":"30","author":"Papillon","year":"1987","journal-title":"Dis Colon Rectum"},{"key":"10.1684\/bdc.2011.1305_bib0050","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/BF01655808","article-title":"Multidisciplinary management of cancer of the anus","volume":"11","author":"Nigro","year":"1987","journal-title":"World J Surg"},{"key":"10.1684\/bdc.2011.1305_bib0055","first-page":"1039","article-title":"Chemoradiotherapy and anal canal cancer","volume":"92","author":"Ortholan","year":"2005","journal-title":"Bull Cancer"},{"key":"10.1684\/bdc.2011.1305_bib0060","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","article-title":"Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1684\/bdc.2011.1305_bib0065","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2011.1305_bib0070","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","article-title":"Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study","volume":"14","author":"Flam","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2011.1305_bib0075","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0167-8140(97)00192-8","article-title":"Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients","volume":"46","author":"Gerard","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1684\/bdc.2011.1305_bib0080","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0360-3016(96)00146-0","article-title":"Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group study","volume":"35","author":"Martenson","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1684\/bdc.2011.1305_bib0085","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1023\/A:1011107105538","article-title":"High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase II study","volume":"12","author":"Peiffert","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1684\/bdc.2011.1305_bib0090","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"key":"10.1684\/bdc.2011.1305_bib0095","first-page":"20","article-title":"A randomized trial of chemoradiation using mitomycin or cisplatin, with or without maintenance cisplatin\/5FU in squamous cell carcinoma of th anus (ACT II)","volume":"2009","author":"James","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2011.1305_bib0100","unstructured":"National Cancer Institute. U.S. National Institute of Health."},{"key":"10.1684\/bdc.2011.1305_bib0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/annonc\/mdp129","article-title":"Anal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up","volume":"20","author":"Glynne-Jones","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1684\/bdc.2011.1305_bib0110","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.bjc.6602486","article-title":"Effective treatment of anal cancer in the elderly with low-dose chemoradiotherapy","volume":"92","author":"Charnley","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1684\/bdc.2011.1305_bib0115","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1080\/02841860600849075","article-title":"Chemoradiotherapy of anal cancer is feasible in elderly patients: treatment results of mitomycin-5-FU combined with radiotherapy at Helsinki University Central Hospital 1992-2003","volume":"45","author":"Saarilahti","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1684\/bdc.2011.1305_bib0120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0167-8140(96)01861-0","article-title":"Age is not a limiting factor for radical radiotherapy in pelvic malignancies","volume":"42","author":"Pignon","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1684\/bdc.2011.1305_bib0125","first-page":"135","article-title":"Management of cancer in the elderly","volume":"20","author":"Balducci","year":"2006","journal-title":"Oncology (Williston Park)"},{"key":"10.1684\/bdc.2011.1305_bib0130","first-page":"799","article-title":"Targeted therapies of cancer: not lost in translation","volume":"93","author":"Blay","year":"2006","journal-title":"Bull Cancer"},{"key":"10.1684\/bdc.2011.1305_bib0135","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1309\/X4UADHVN317V2XMW","article-title":"Epidermal growth factor receptor expression in anal canal carcinoma","volume":"124","author":"Le","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1684\/bdc.2011.1305_bib0140","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/modpathol.3800608","article-title":"Expression of epidermal growth factor receptor in squamous cell carcinomas of the anal canal is independent of gene amplification","volume":"19","author":"Alvarez","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1684\/bdc.2011.1305_bib0145","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.humpath.2009.05.010","article-title":"Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus","volume":"40","author":"Walker","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1684\/bdc.2011.1305_bib0150","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1200\/JCO.2009.21.9170","article-title":"American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy","volume":"27","author":"Allegra","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2011.1305_bib0155","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/sj.bjc.6603685","article-title":"Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy","volume":"96","author":"Di Fiore","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1684\/bdc.2011.1305_bib0160","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1158\/0008-5472.CAN-06-0191","article-title":"KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer","volume":"66","author":"Lievre","year":"2006","journal-title":"Cancer Res"},{"key":"10.1684\/bdc.2011.1305_bib0165","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/path.1711610203","article-title":"Ki-ras oncogene mutations in non-HPV-associated anal carcinoma","volume":"161","author":"Hiorns","year":"1990","journal-title":"J Pathol"},{"key":"10.1684\/bdc.2011.1305_bib0170","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00280-009-1117-3","article-title":"K-ras status in squamous cell anal carcinoma (SCC): it's time for target-oriented treatment?","volume":"65","author":"Zampino","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1684\/bdc.2011.1305_bib0175","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000259615","article-title":"Cetuximab-based treatment of metastatic anal cancer: correlation of response with KRAS mutational status","volume":"77","author":"Lukan","year":"2009","journal-title":"Oncology"},{"key":"10.1684\/bdc.2011.1305_bib0180","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1684\/bdc.2011.1305_bib0185","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0167-8140(93)90076-K","article-title":"Chemoradiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatin","volume":"27","author":"Rich","year":"1993","journal-title":"Radiother Oncol"},{"key":"10.1684\/bdc.2011.1305_bib0190","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115306822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115306822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T08:43:04Z","timestamp":1602492184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455115306822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0007455115306822"],"URL":"https:\/\/doi.org\/10.1684\/bdc.2011.1305","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}